News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Epperly Melissa B,
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 4,594 shares
@ $19.4265, valued at
$89.2k
Sold 888 shares
@ $19.9102, valued at
$17.7k
|
|
| 10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| Epperly Melissa B, (Director) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Granted 1,280 shares
@ $0 |
|
| 06/16/2023 |
4
| Epperly Melissa B, (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.|
Txns:
| Granted 45,000 options to buy
@ $3.97, valued at
$178.7k
|
|
| 02/14/2023 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 2,624 shares
@ $20.4244, valued at
$53.6k
Sold 5,227 shares
@ $19.9753, valued at
$104.4k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Epperly Melissa B, (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $8.38, valued at
$169.7k
|
|
| 04/05/2022 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 8,094 shares
@ $48.7475, valued at
$394.6k
Sold 1,303 shares
@ $49.9018, valued at
$65k
Sold 2,818 shares
@ $50.6975, valued at
$142.9k
Sold 4,512 shares
@ $51.9862, valued at
$234.6k
Sold 353 shares
@ $52.4386, valued at
$18.5k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 16,405 shares
@ $0
Granted 38,489 options to buy
@ $52.61, valued at
$2M
|
|
| 10/04/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 17,080 shares
@ $67.13, valued at
$1.1M
|
|
| 07/06/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 700 shares
@ $50.1043, valued at
$35.1k
Sold 1,378 shares
@ $51.1461, valued at
$70.5k
Sold 805 shares
@ $52.0062, valued at
$41.9k
Sold 200 shares
@ $53.185, valued at
$10.6k
|
|
| 06/14/2021 |
4
| Epperly Melissa B, (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $24.46, valued at
$495.3k
|
|
| 06/09/2021 |
3
| Epperly Melissa B, (Director) has filed a Form 3 on Nautilus Biotechnology, Inc. |
| 06/02/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 2,883 shares
@ $53.9927, valued at
$155.7k
Sold 200 shares
@ $54.9, valued at
$11k
|
|
| 05/05/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 350 shares
@ $56.9943, valued at
$19.9k
Sold 661 shares
@ $58.0449, valued at
$38.4k
Sold 950 shares
@ $59.8307, valued at
$56.8k
Sold 1,122 shares
@ $60.1425, valued at
$67.5k
|
|
| 04/06/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,083 shares
@ $43.4303, valued at
$133.9k
Sold 13,792 shares
@ $43.3657, valued at
$598.1k
Sold 149 shares
@ $44.2148, valued at
$6.6k
Sold 83 shares
@ $45.0606, valued at
$3.7k
|
|
| 03/03/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,083 shares
@ $41.6745, valued at
$128.5k
|
|
| 02/16/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 45,000 options to buy
@ $38.76, valued at
$1.7M
|
|
| 02/03/2021 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 2,700 shares
@ $37.4528, valued at
$101.1k
Sold 383 shares
@ $38.3345, valued at
$14.7k
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2020 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 3,343 shares
@ $50.7627, valued at
$169.7k
Sold 3,877 shares
@ $51.1728, valued at
$198.4k
Sold 119 shares
@ $50.839, valued at
$6k
Sold 971 shares
@ $52.5293, valued at
$51k
Sold 4,983 shares
@ $53.7111, valued at
$267.6k
Sold 391 shares
@ $54.3863, valued at
$21.3k
|
|
| 12/03/2020 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 700 shares
@ $50.3386, valued at
$35.2k
Sold 1,525 shares
@ $51.3267, valued at
$78.3k
Sold 500 shares
@ $52.272, valued at
$26.1k
Sold 358 shares
@ $53.1691, valued at
$19k
|
|
| 12/02/2020 |
3
| Epperly Melissa B, (Director) has filed a Form 3 on Kinnate Biopharma Inc. |
| 11/25/2020 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $18, valued at
$360k
Sold 2,783 shares
@ $46.5097, valued at
$129.4k
Sold 300 shares
@ $47.2567, valued at
$14.2k
|
|
| 04/09/2020 |
4
| Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 147,394 shares
@ $0 |
|
| 04/03/2020 |
3
| Epperly Melissa B, (CFO) has filed a Form 3 on Zentalis Pharmaceuticals, LLC |
|
|